14
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A pilot study on adjunctive use of parametric colour-coded digital subtraction angiography in endovascular interventions of haemodialysis access

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Two-dimensional digital subtraction angiography (DSA) is the gold standard for angiographic evaluation of dysfunctional haemodialysis access. We aim to investigate the utility of parametric colour coded DSA in providing hemodynamic analysis during haemodialysis access interventions.

          Methods

          We retrospectively studied 20 patients who underwent access intervention and applied parametric colour-coding on selected DSA acquisitions before and after percutaneous transluminal angioplasty (PTA). The difference in time to peak (dTTP) contrast enhancement and time attenuation curve (TAC) of pre- and post-stenotic regions of interest (ROIs) were obtained and compared after treatment.

          Results

          Improvements were seen in mean percent of stenosis after PTA ( p < 0.0001) for all cases. Median dTTP improved from 0.52 (IQR 0.26, 0.8) to 0.25 (IQR 0, 0.26) seconds ( p = 0.001). Median 50% contrast washout time improved from 0.77 (IQR 0.39, 1.17) to 0.42 (IQR 0.23, 0.59) seconds ( p = 0.031). Significant correlation was seen for dTTP vs. percent of stenosis ( r = 0.723, p = 0.043) pre-PTA and for change in dTTP vs. percent change in stenosis post-PTA ( r = 0.786, p = 0.021) for inflow lesions. Such correlation was however not seen in outflow lesions.

          Conclusions

          Adjunctive use of parametric colour-coded DSA may provide potentially useful hemodynamic information during vascular access interventions. Larger prospective studies are needed to validate our findings.

          Related collections

          Most cited references26

          • Record: found
          • Abstract: found
          • Article: not found

          Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint.

          Hemodialysis vascular access dysfunction is a major cause of morbidity and hospitalization in the hemodialysis population. The major cause of hemodialysis vascular access dysfunction is venous stenosis as a result of neointimal hyperplasia. Despite the magnitude of the clinical problem, however, there has been a paucity of novel therapeutic interventions in this field. This is in marked contrast to a recent plethora of targeted interventions for the treatment of arterial neointimal hyperplasia after coronary angioplasty. The reasons for this are two-fold. First there has been a relative lack of cellular and molecular research that focuses on venous neointimal hyperplasia in the specific setting of hemodialysis vascular access. Second, there have been inadequate efforts by the nephrology community to translate the recent advances in molecular and interventional cardiology into therapies for hemodialysis vascular access. This review therefore (1) briefly examines the different forms of hemodialysis vascular access that are available, (2) describes the pathology and pathogenesis of hemodialysis vascular access dysfunction in both polytetrafluoroethylene grafts and native arteriovenous fistulae, (3) reviews recent concepts about the pathogenesis of vascular stenosis that could potentially be applied in the setting of hemodialysis vascular access dysfunction, (4) summarizes novel experimental and clinical therapies that could potentially be used in the setting of hemodialysis vascular access dysfunction, and, finally, (5) offers some broad guidelines for future innovative translational and clinical research in this area that hopefully will reduce the huge clinical morbidity and economic costs that are associated with this condition.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Outcomes of arteriovenous fistula creation after the Fistula First Initiative.

            The arteriovenous fistula (AVF) is the preferred hemodialysis access, but AVF-failure rate is high, and complications from AVF placement are rarely reported. There is no clear consensus on predictors of AVF patency. This study determined AVF outcomes and patency predictors at Mayo Clinic Rochester following the Fistula First Initiative. A retrospective cohort study of AVFs placed at Mayo Clinic from January 2006 through December 2008 was performed. The AVF placement-associated primary and secondary failure rates, complications, interventions, and hospitalizations were examined. Kaplan-Meier survival curves and Cox proportional hazard models were used to determine primary and secondary patency and associated predictors. During this time frame, 317 AVFs were placed in 293 individual patients. The primary failure rate was 37.1% after excluding patients not initiated on hemodialysis during follow-up (n = 38) or those with indeterminate outcome (37 lost to follow-up; six died; two transplanted). Of usable AVFs, 11.4% later failed. AVF creation incurred complications and hospitalization in 21.2% and 12.3% of patients, respectively. The risk for reduced primary patency was increased by diabetes (HR, 1.54; 95% CI, 1.14 to 2.07); the risk for reduced primary and secondary patency was decreased with larger arteries (HR, 0.83; 95% CI, 0.73 to 0.94; and HR, 0.69; 95% CI, 0.56 to 0.84, respectively). Primary failure remains a major issue in the post-Fistula First era. Complications from AVF placement must be considered when planning AVF placement. Our data demonstrate that artery size is the main predictor of AVF patency.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Reporting standards for percutaneous interventions in dialysis access.

                Bookmark

                Author and article information

                Contributors
                (65) 63214436 , tan.ru.yu@singhealth.com.sg
                chong.tze.tec@singhealth.com.sg
                jack.tsai.f.c@sgh.com.sg
                pang.suh.chien@singhealth.com.sg
                darrenkg@gmail.com
                apoorva.gogna@singhealth.com.sg
                aliciaohy@gmail.com
                tan.chieh.suai@singhealth.com.sg
                Journal
                BMC Med Imaging
                BMC Med Imaging
                BMC Medical Imaging
                BioMed Central (London )
                1471-2342
                15 September 2018
                15 September 2018
                2018
                : 18
                : 28
                Affiliations
                [1 ]ISNI 0000 0000 9486 5048, GRID grid.163555.1, Department of Renal Medicine, , Singapore General Hospital, ; Singapore, Singapore
                [2 ]ISNI 0000 0000 9486 5048, GRID grid.163555.1, Department of Vascular Surgery, , Singapore General Hospital, ; Singapore, Singapore
                [3 ]ISNI 0000 0000 9486 5048, GRID grid.163555.1, Department of Vascular and Interventional Radiology, , Singapore General Hospital, ; Singapore, Singapore
                [4 ]ISNI 0000 0004 0385 0924, GRID grid.428397.3, Duke-NUS Medical School, ; Singapore, Singapore
                Author information
                http://orcid.org/0000-0003-1491-2302
                Article
                270
                10.1186/s12880-018-0270-8
                6139131
                30219054
                3057f6fb-9bf5-4ce1-b637-5b7176818891
                © The Author(s). 2018

                Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 9 July 2018
                : 24 August 2018
                Categories
                Research Article
                Custom metadata
                © The Author(s) 2018

                Radiology & Imaging
                colour-coded,digital subtraction angiography,haemodialysis,vascular access,endovascular intervention

                Comments

                Comment on this article